ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Emagine Solutions Technology Wins $1 Million in R&D Funding from the U.S. National Science Foundation

Latest fundraising effort to strengthen Emagine’s powerful suite of maternal health tools

Emagine Solutions Technology has been awarded $1 million from the U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) program to conduct research and development (R&D) work on further developing proprietary AI models as well as integrating their systems with the biggest Electronic Health Record (EHR) system in the nation, making The Journey Pregnancy App a more robust tool for patients and medical professionals.

Emagine addresses the maternal health crisis with remote patient monitoring technology designed to improve pregnancy care. Their continuing effort to increase access to vital maternal health tools comes amid reports that the U.S. has the highest maternal mortality in the developed world. Meanwhile, maternal health disparities are actually increasing, particularly within communities of color, who face systemic inequalities when interacting with the healthcare system.

“The US maternal health crisis is felt by every community in our country,” says Emagine Solutions Technology Co-founder and CEO Courtney Williams. “The National Science Foundation provides vital funding, policy and support that allows us to develop much-needed solutions, capture the attention of the nation and drive real change.”

The Journey Pregnancy App is available for free at Apple’s App Store and Google Play. For more info, visit: thejourney.health.

About Emagine Solutions Technology

An award-winning healthcare technology company, Emagine is your companion for a safe pregnancy. Offering handheld ultrasound technology and remote patient monitoring software, we provide a new level of care to improve maternal health outcomes. To find out more, visit emaginest.com and follow Emagine on Instagram, Twitter, TikTok and Facebook.

About the U.S. National Science Foundation's Small Business Programs

America’s Seed Fund powered by NSF awards more than $200 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. Startups working across almost all areas of science and technology can receive up to $2 million to support research and development (R&D), helping de-risk technology for commercial success. America’s Seed Fund is congressionally mandated through the Small Business Innovation Research (SBIR) program. The NSF is an independent federal agency with a budget of about $9.5 billion that supports fundamental research and education across all fields of science and engineering.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.